In particular, human vascular endothelial cells treated with Spike have been found to release both TGF-β1 and TGF-β2 [17], consistent with previous “in vivo” evidence suggesting a key role of TGF-β in COVID-19 pathogenesis [18,19]. This evidence concerns the gene TGFB1 and COVID-19.